USA - NASDAQ:SGRY - US86881A1007 - Common Stock
The current stock price of SGRY is 21.87 USD. In the past month the price decreased by -2.8%. In the past year, price decreased by -29.45%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 16.92 | 94.80B | ||
THC | TENET HEALTHCARE CORP | 13.07 | 17.04B | ||
EHC | ENCOMPASS HEALTH CORP | 25.36 | 12.70B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 10.19 | 12.20B | ||
ENSG | ENSIGN GROUP INC/THE | 28.05 | 9.69B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 18.01 | 2.84B | ||
ACHC | ACADIA HEALTHCARE CO INC | 7.82 | 2.01B | ||
ARDT | ARDENT HEALTH INC | 7.31 | 1.87B | ||
BKD | BROOKDALE SENIOR LIVING INC | N/A | 1.78B | ||
NHC | NATIONAL HEALTHCARE CORP | 17.14 | 1.78B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 11.8 | 1.55B | ||
PACS | PACS GROUP INC | 12.83 | 1.51B |
Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. The company is headquartered in Brentwood, Tennessee and currently employs 15,000 full-time employees. The company went IPO on 2015-10-01. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The firm operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The firm operates a portfolio of 161 surgical facilities comprised of 142 ASCs and 19 surgical hospitals. The firm is focused on surgical services businesses in the United States, with over 200 locations in 31 states, including short-stay surgical hospitals.
SURGERY PARTNERS INC
310 Seven Springs Way, Suite 500
Brentwood TENNESSEE 37027 US
CEO: J. Eric Evans
Employees: 15000
Phone: 16152345900
The current stock price of SGRY is 21.87 USD. The price decreased by -1.09% in the last trading session.
The exchange symbol of SURGERY PARTNERS INC is SGRY and it is listed on the Nasdaq exchange.
SGRY stock is listed on the Nasdaq exchange.
19 analysts have analysed SGRY and the average price target is 31.99 USD. This implies a price increase of 46.28% is expected in the next year compared to the current price of 21.87. Check the SURGERY PARTNERS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SURGERY PARTNERS INC (SGRY) has a market capitalization of 2.80B USD. This makes SGRY a Mid Cap stock.
SURGERY PARTNERS INC (SGRY) currently has 15000 employees.
SURGERY PARTNERS INC (SGRY) has a support level at 19.61 and a resistance level at 22.21. Check the full technical report for a detailed analysis of SGRY support and resistance levels.
The Revenue of SURGERY PARTNERS INC (SGRY) is expected to grow by 9.01% in the next year. Check the estimates tab for more information on the SGRY EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SGRY does not pay a dividend.
SURGERY PARTNERS INC (SGRY) will report earnings on 2025-11-10, before the market open.
The PE ratio for SURGERY PARTNERS INC (SGRY) is 26.04. This is based on the reported non-GAAP earnings per share of 0.84 and the current share price of 21.87 USD. Check the full fundamental report for a full analysis of the valuation metrics for SGRY.
The outstanding short interest for SURGERY PARTNERS INC (SGRY) is 16.69% of its float. Check the ownership tab for more information on the SGRY short interest.
ChartMill assigns a fundamental rating of 3 / 10 to SGRY. SGRY has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months SGRY reported a non-GAAP Earnings per Share(EPS) of 0.84. The EPS decreased by -10.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.27% | ||
ROE | -10.32% | ||
Debt/Equity | 1.98 |
19 analysts have analysed SGRY and the average price target is 31.99 USD. This implies a price increase of 46.28% is expected in the next year compared to the current price of 21.87.
For the next year, analysts expect an EPS growth of -8.14% and a revenue growth 9.01% for SGRY